ISU ABXIS to release first antibodytherapeutic

ISU ABXIS Inc., a local biotechnology specialized in developing and manufacturing therapeutic antibodies, said it will launch its first antibody therapeutic Clotinab (anti-GP IIb/IIIa mAb), followed by the development of other four therapeutic proteins in the pipeline.

ISU ABXIS's Clotinab, the country's first therapeutic antibody, was recently approved by the Korea Food and Drug Administrat...